Semaglutide , the active ingredient in the drugs Ozempic , Wegovy , and Rybelsus, is well known for its ability to cause weight loss , control blood sugar, and reduce cardiovascular risk
This patch helps suppress appetite, supporting portion control and reducing the temptation to overeat
At lower doses, this medication may not provide enough appetite control
For patients concerned about losing lean muscle mass while using semaglutide or tirzepatide, however, there is some good news: A new study conducted by obesity specialists in New York found that incorporating resistance training, increasing protein intake, and reducing the speed of weight loss can mitigate the risk of GLP-1-associated muscle loss
Providers should rely on FDA labeling, and applicable state and federal regulations when prescribing or administering GLP-1 medications
While microdosing may reduce side effects, its different from a medically guided titration plan